Arbovax

Arbovax is a biotechnology company focused on developing vaccines for arthropod-borne viruses, commonly known as arboviruses. The company's core technology, Host-Range Restriction (HRR), allows for the creation of live-attenuated vaccines that can replicate in insect cells but are unable to replicate in human cells. This unique approach is designed to produce vaccines that are both safe and highly effective at inducing an immune response. Their primary targets include widespread tropical diseases such as Dengue fever, Zika virus, and Chikungunya. Based in Raleigh, North Carolina, the company was founded on research conducted at North Carolina State University. Arbovax aims to provide cost-effective vaccine solutions to address significant unmet needs in global infectious disease management.